News	Events
Publications	Companies
Clinical Trials

Monthly Archives: June 2004

• Santaris Pharma raises EUR 4.4 million in interim funding from lead investors and launches second round financing

  0 Replies
  

  June 29, 2004

  Copenhagen, 29th June 2005 Santaris Pharma, the Danish biopharmaceutical company developing gene-targeting drugs for the treatment of cancer, today announced that it has received additional financing of EUR 4.4 million from its lead investors: BankInvest, Novo, LD Pension, InnovationsKapital, Dansk Kapitalanlæg and Dansk Erhvervsinvestering. read more Contine Reading & Discuss→